Cargando…

The Antiglaucoma Agent and EP2 Receptor Agonist Omidenepag Does Not Affect Eyelash Growth in Mice

Purpose: The present study investigated the effects of the antiglaucoma agent and selective E2 receptor agonist omidenepag isopropyl (OMDI) on eyelash growth in comparison with a prostaglandin analog (prostamide receptor agonist) in mice. Methods: Four-week-old female mice (C57BL/6J) were divided in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Esaki, Yoshihiko, Katsuta, Osamu, Kamio, Hitomi, Noto, Takahisa, Mano, Hidetoshi, Iwamura, Ryo, Yoneda, Kenji, Odani-Kawabata, Noriko, Morishima, Kenji, Shams, Naveed K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482127/ https://www.ncbi.nlm.nih.gov/pubmed/32412835 http://dx.doi.org/10.1089/jop.2020.0003

Ejemplares similares

Effects of the Selective EP2 Receptor Agonist Omidenepag on Adipocyte Differentiation in 3T3-L1 Cells
por: Yamamoto, Yasuko, et al.
Publicado: (2020)

Downregulation of COL12A1 and COL13A1 by a selective EP2 receptor agonist, omidenepag, in human trabecular meshwork cells
por: Kumon, Masashi, et al.
Publicado: (2023)

Pharmacokinetics, Safety, and Intraocular Pressure-Lowering Profile of Omidenepag Isopropyl, a Selective, Nonprostaglandin, Prostanoid EP2 Receptor Agonist, in Healthy Japanese and Caucasian Volunteers (Phase I Study)
por: Aihara, Makoto, et al.
Publicado: (2019)

A Randomized Phase 2 Trial Comparing Omidenepag Isopropyl 0.002% Once and Twice Daily in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (SPECTRUM-6)
por: Olander, Kenneth W., et al.
Publicado: (2021)

Antiglaucoma pharmacotherapy
por: Tătaru, CP, et al.
Publicado: (2012)

Eyelashes
Publicado: (1871)

Short-Term Efficacy and Safety of Omidenepag Isopropyl in Patients with Normal-Tension Glaucoma
por: Inoue, Kenji, et al.
Publicado: (2020)

Omidenepag Isopropyl in Latanoprost Low/Nonresponders With Primary Open Angle Glaucoma or Ocular Hypertension: A Phase 3, Nonrandomized, Two-Phase, Open-Label Study
por: Panarelli, Joseph F., et al.
Publicado: (2023)

Eyelash Transplantation for the Treatment of Vitiligo Associated Eyelash Leucotrichia
por: Chatterjee, Manas, et al.
Publicado: (2016)

Epilation of eyelashes
por: Stevens, Sue
Publicado: (2008)

Eyelash Trichomegaly
por: Kaur, Sandeep, et al.
Publicado: (2015)

Ingrowing Eyelashes
por: Moore, William Oliver
Publicado: (1883)

Corneal Opacity Induced by Antiglaucoma Agents Other Than Brimonidine Tartrate
por: Kasuya, Yuka, et al.
Publicado: (2020)

Twenty-Four-Hour Intraocular Pressure Control with Omidenepag Isopropyl 0.002% in Patients with Glaucoma and Ocular Hypertension
por: Shiratori, Naka, et al.
Publicado: (2021)

Omidenepag, a Selective, Prostanoid EP2 Agonist, Does Not Suppress Adipogenesis in 3D Organoids of Human Orbital Fibroblasts
por: Hikage, Fumihito, et al.
Publicado: (2021)

Bilateral hamartomatous medullary lipoma within the nasal turbinate bones in a cynomolgus monkey (Macaca fascicularis)
por: KATSUTA, Osamu, et al.
Publicado: (2016)

Spontaneous nephroblastoma with oncocytic differentiation in a Japanese White rabbit
por: Katsuta, Osamu, et al.
Publicado: (2017)

Essential Trichomegaly of the Eyelashes
por: Fernández-Crehuet, Pablo, et al.
Publicado: (2016)

Intraocular incarceration of eyelash
por: Kumar, Karthik, et al.
Publicado: (2020)

Lady with Long Eyelashes…!
por: Inamadar, Soumya S., et al.
Publicado: (2022)

Effects of selective EP2 receptor agonist, omidenepag, on trabecular meshwork cells, Schlemm’s canal endothelial cells and ciliary muscle contraction
por: Nakamura, Natsuko, et al.
Publicado: (2021)

Controversy: Is Benzalkonium Chloride Necessary in Antiglaucoma Drops?
por: Louati, Y, et al.
Publicado: (2012)

Antioxidant, Antidiabetic, Anticholinergic, and Antiglaucoma Effects of Magnofluorine
por: Durmaz, Lokman, et al.
Publicado: (2022)

Omidenepag, a non-prostanoid EP2 receptor agonist, induces enlargement of the 3D organoid of 3T3-L1 cells
por: Ida, Yosuke, et al.
Publicado: (2020)

Bimatoprost in the treatment of eyelash hypotrichosis
por: Law, Simon K
Publicado: (2010)

Erlotinib Induced Trichomegaly of the Eyelashes
por: Jeon, Sang-Hoon, et al.
Publicado: (2013)

Dramatic and persistent loss of eyelashes
por: Venneuguès, Rowena Vicencio, et al.
Publicado: (2015)

Dermoscopy in atypical phthiriais eyelash
por: Sanaa, Krich, et al.
Publicado: (2016)

A closer look at the eyelashes!
por: Belkhadir, Kawtar, et al.
Publicado: (2019)

Reactivities of a Prostanoid EP2 Agonist, Omidenepag, Are Useful for Distinguishing between 3D Spheroids of Human Orbital Fibroblasts without or with Graves’ Orbitopathy
por: Ida, Yosuke, et al.
Publicado: (2021)

Efficacy and Patient Tolerability of Omidenepag Isopropyl in the Treatment of Glaucoma and Ocular Hypertension
por: Matsuo, Masato, et al.
Publicado: (2022)

Evaluation of early medication persistence with omidenepag isopropyl, a topical selective prostaglandin EP2 agonist, in patients with glaucoma: a retrospective two-institute study
por: Nakakura, Shunsuke, et al.
Publicado: (2021)

Management of hypotrichosis of the eyelashes: Focus on bimatoprost
por: Fagien, Steven
Publicado: (2010)

Development and Validation of the Eyelash Satisfaction Questionnaire
por: Dang, Jeff, et al.
Publicado: (2016)

Getting hooked: Eyelash in lacrimal punctum
por: Singh, Swati, et al.
Publicado: (2017)

Phthiriasis palpebrarum in a woman's eyelashes
por: Shin, Eunhae, et al.
Publicado: (2020)

Impact and Management of Loss of Eyebrows and Eyelashes
por: Starace, Michela, et al.
Publicado: (2023)

Eyelash length attractiveness across ethnicities
por: Pazhoohi, Farid, et al.
Publicado: (2023)

Case report: Head lice in the eyelashes
por: Qin, Tingyu, et al.
Publicado: (2023)

Antiglaucoma drugs for achieving monovision after laser in situ keratomileusis
por: Kamiya, Kazutaka, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_kur7u3l805hafnfckcr7nlufmu